Ketamine for PTSD
Find clinics offering ketamine therapy for post-traumatic stress disorder.
Reviewed for clinical accuracy against peer-reviewed literature and FDA guidelines · Last reviewed March 2026
💪 Ketamine Therapy for PTSD: What You Need to Know
Post-traumatic stress disorder (PTSD) affects approximately 6% of the U.S. population at some point in their lives, with even higher rates among military veterans, first responders, and survivors of sexual assault. While evidence-based treatments like EMDR (Eye Movement Desensitization and Reprocessing) and CPT (Cognitive Processing Therapy) are effective for many, an estimated 30-50% of PTSD patients do not achieve adequate relief from these standard approaches.
Ketamine therapy has emerged as a powerful option for treatment-resistant PTSD, offering rapid symptom relief and a unique ability to enhance the processing of traumatic memories. When combined with psychotherapy in a modality known as Ketamine-Assisted Psychotherapy (KAP), ketamine can help patients access and reprocess traumatic experiences in a way that traditional talk therapy alone may not achieve.
Ketamine clinics across the United States now offer specialized PTSD treatment protocols, including both standalone ketamine infusions and integrated KAP programs. Many of these clinics have experience working with military veterans, sexual trauma survivors, and first responders who face unique challenges in trauma recovery.
How Ketamine Works for PTSD
Ketamine's mechanism for PTSD treatment involves several interconnected pathways. At the neurobiological level, NMDA receptors play a critical role in fear conditioning — the process by which the brain forms and stores traumatic memories. By blocking NMDA receptors, ketamine may facilitate memory reconsolidation, a process where traumatic memories are retrieved and then stored in a modified, less distressing form. This can help reduce the intense emotional charge associated with traumatic memories.
Ketamine also enhances extinction learning — the brain's ability to form new, non-threatening associations with previously feared stimuli. This is the same mechanism that underlies exposure-based therapies, but ketamine accelerates the process. Additionally, the mild dissociative state induced by ketamine can provide patients with psychological distance from their trauma, allowing them to engage with traumatic material therapeutically without becoming overwhelmed. This makes Ketamine-Assisted Psychotherapy (KAP) particularly effective for trauma processing.
Clinical Evidence
Randomized controlled trials by Feder et al. (2014, 2021) demonstrated that IV ketamine produced rapid and significant reductions in PTSD symptom severity compared to placebo, with effects emerging within 24 hours of a single infusion. The 2021 study specifically showed that repeated ketamine infusions over two weeks led to sustained improvement in PTSD symptoms. Ketamine-Assisted Psychotherapy (KAP) has shown particularly promising results in trauma populations, with multiple studies reporting clinically meaningful improvements in PTSD severity scores.
Who Is a Candidate?
Strong candidates for ketamine therapy for PTSD include patients who have been diagnosed with PTSD and have not responded adequately to first-line treatments such as EMDR, CPT, or prolonged exposure therapy, as well as those who have failed SSRI medications (sertraline and paroxetine are FDA-approved for PTSD). Combat veterans, sexual trauma survivors, and first responders with treatment-resistant PTSD are frequently treated at ketamine clinics. Patients who experience severe hyperarousal, flashbacks, or emotional numbing that impairs daily functioning are also appropriate candidates.
Side Effects to Consider
During ketamine treatment for PTSD, patients may experience dissociation, which can occasionally trigger trauma-related sensations or memories. This is monitored closely by the clinical team, and the dissociative experience is often therapeutically integrated when KAP is used. Other common side effects include dizziness, nausea, elevated blood pressure, and fatigue. PTSD patients should be treated at clinics with trauma-informed staff who can manage any emotional responses that arise during sessions. Side effects are typically short-lived and resolve within 1-2 hours post-treatment.
Frequently Asked Questions
Common questions about ketamine therapy for post-traumatic stress disorder.
Does ketamine help with PTSD?
Yes, clinical research strongly supports ketamine's effectiveness for PTSD. Randomized controlled trials by Feder et al. (2014, 2021) published in JAMA Psychiatry and the American Journal of Psychiatry demonstrated that IV ketamine produced rapid and significant reductions in PTSD symptom severity compared to placebo, with effects emerging within 24 hours of a single infusion. Ketamine can reduce the full spectrum of PTSD symptoms including intrusive thoughts, hyperarousal, avoidance behaviors, and emotional numbing. Ketamine-Assisted Psychotherapy (KAP), which combines ketamine with trauma-focused therapy, has shown particularly strong results because the neuroplasticity window created by ketamine allows deeper processing of traumatic memories. An estimated 30–50% of PTSD patients do not achieve adequate relief from standard treatments like EMDR and cognitive processing therapy, making ketamine a valuable option for treatment-resistant cases. Consult a trauma-informed ketamine provider to discuss whether standalone infusions or KAP would be most appropriate for your situation.
How does ketamine treat trauma?
Ketamine helps treat trauma through several interconnected neurobiological mechanisms that address the root causes of PTSD rather than simply masking symptoms. First, it facilitates memory reconsolidation — the process by which traumatic memories are retrieved and then stored in a modified, less emotionally distressing form — through its action on NMDA receptors, which play a critical role in fear conditioning. Second, ketamine enhances extinction learning, helping the brain form new, non-threatening associations with previously feared stimuli, which is the same mechanism underlying exposure-based therapies but at an accelerated pace. Third, it promotes neuroplasticity through increased BDNF production in brain regions damaged by chronic trauma, such as the prefrontal cortex and hippocampus. The mild therapeutic dissociation during treatment can also provide patients with psychological distance from traumatic material, enabling deeper processing without becoming overwhelmed. For these reasons, many clinicians recommend combining ketamine with trauma-focused psychotherapy to maximize therapeutic benefits.
Is ketamine better than EMDR for PTSD?
Ketamine and EMDR are not mutually exclusive — they address PTSD through different neurobiological mechanisms and can be complementary rather than competing treatments. EMDR remains a first-line evidence-based treatment recommended by the American Psychological Association and is effective for many patients, particularly those with single-incident trauma. Ketamine is typically considered when EMDR, cognitive processing therapy, and other standard approaches have not provided sufficient relief, as an estimated 30–50% of PTSD patients do not respond adequately to these first-line treatments. Some clinicians are now combining ketamine with trauma-focused therapies such as EMDR or prolonged exposure during the neuroplasticity window that ketamine creates, reporting enhanced outcomes for patients with treatment-resistant PTSD. There are no large head-to-head trials directly comparing ketamine to EMDR, so the choice depends on your treatment history, symptom severity, and access to qualified providers. Ask your clinician about an integrated approach if standard therapy alone has been insufficient.
Can veterans get ketamine for PTSD?
Yes, many ketamine clinics across the United States specialize in treating veterans with PTSD, and several pathways exist for access. While the VA healthcare system has limited direct ketamine availability at this time, numerous private ketamine clinics have developed specific veteran programs and may offer military discounts of 10–20% off standard pricing. Some veterans use VA Community Care referrals to access ketamine treatment at private clinics when the VA cannot provide equivalent services locally. Organizations like the Veterans Exploring Treatment Solutions (VETS) help connect veterans with ketamine therapy providers and may assist with funding. PTSD affects veterans at significantly higher rates than the general population, with an estimated 11–20% of veterans who served in Iraq and Afghanistan experiencing PTSD. Given these numbers, access to rapid-acting treatments like ketamine is especially important for this population. Contact your VA coordinator or a local ketamine clinic directly to explore all available treatment and financing options.
References
- Feder A et al. (2014) JAMA Psychiatry. First RCT of ketamine in PTSD demonstrated rapid and significant reduction in PTSD symptom severity within 24 hours compared to midazolam. [DOI]
- Feder A et al. (2021) Am J Psychiatry. Repeated IV ketamine infusions produced significant and sustained improvements in chronic PTSD symptoms over two weeks. [DOI]
- Du R et al. (2022) Front Psychiatry. Systematic review and meta-analysis confirmed ketamine has significant multivariate effects on PTSD symptoms, depression, and anxiety in PTSD patients. [DOI]
Treatment Types for PTSD
Explore the different ways ketamine therapy can be administered for post-traumatic stress disorder.
IV Ketamine Infusion
Intravenous delivery. Fastest onset, 60-70% response rate. $400-800/session.
Spravato (Esketamine)
FDA-approved nasal spray. Often insurance-covered. $590-885/session.
IM Injection
Intramuscular injection. Similar efficacy, lower cost. $250-500/session.
KAP (Ketamine-Assisted Psychotherapy)
Combines ketamine with guided psychotherapy. $500-1,500/session.